Third Rock Ventures IV, L.P., 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 401,198 shares at $9.87 ($3.9M) on 2024-07-25, disclosed to the SEC on 2024-07-26.
Open-market sale of $3.9M TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.82 | 200,000 | $2.0M | 49.7% |
| 2 | $9.87 | 100,599 | $993K | 25.1% |
| 3 | $9.87 | 100,599 | $993K | 25.1% |
| Total | $9.85 avg | 401,198 | $3.9M | 100% |
| Filing → |
| TNGX | SELL | 2024-07-22 | $3.8M | — | Filing → |
| TNGX | SELL | 2024-02-21 | $1.9M | — | Filing → |